| Title | Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (OPUS) |
|---|---|
| Disease/Condition | Neurology,Epilepsy |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Alexis Boro, MD |
| Contact Name | Darlene Rozon |
| Contact Email | drozon@montefiore.org |
| IRB/Protocol Number | 17-02-374-01 |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |